More than 150 companies have fixed record dates for dividends and stock splits between September 21 and September 25. IRCTC, BEML, Hindusta...

Currently at the pre-clinical stage of development, the patented insulin eye drops are being investigated as a potential novel therapeutic ...

Pharmaceutical companies will soon find it easier to conduct drug studies. Applicants can start eligible trials after intimating the drug r...

At a time when fears of AI are gripping the public, the startup has built a wet lab, or place for physical experiments, in the San Francisc...

Theranautilus won the Top Innovator category at The Economic Times Startup Awards 2026 for its unique nanorobot technology, which is built ...

Capitalmind Flexi Cap Fund made five fresh additions and completely exited five stocks from its portfolio in August, while keeping its expo...

The investment will help Nutriventia strengthen its research and development pipeline, expand its global commercial presence and scale its ...

Amid the backdrop of increasing US interest rates in August, fund managers proceeded with caution, prioritizing large-cap stocks that offer...

On September 16, Indian markets experienced a careful resurgence, with the Nifty and Sensex both moving upwards. This rebound was fueled by...

JM Financial retained Buy ratings on Dr Reddy’s Laboratories and Aurobindo Pharma, seeing up to 28% upside over the next 12 months. The bro...

The Rs 550 crore public issue was priced at Rs 676 per share. The offering comprised a fresh issue of 11.83 lakh shares worth Rs 80 crore a...

A major fake cancer drug racket has been busted in Karnataka, with investigators alleging that a licensed pharmacist supplied counterfeit m...

Wise men on the street will tell you it is foolish to try and time the market. And attempting to do so in the midst of a raging war is prob...

Belarus seeks deeper industrial and agro sector cooperation with India. The nation is ready for joint ventures and local production in Indi...

The new funds will be used to expand across the US and Europe, as the startup looks to change the pharmacovigilance industry’s services-hea...

Amitabh Dube has been appointed as the new president of OPPI for a two-year term. Dube currently serves as the Country President and Managi...

Rating agencies Moody's and S&P assigned investment-grade ratings to Sun Pharmaceutical Industries. This action follows Sun Pharma's propos...